The present studies were performed to elucidate several physiological and clinical questions of calcitonin (CT) and parathyroid hormone-related protein (PTHrP) such as: a) Does age influence the basal and calcium-stimulated levels and circulating molecular forms of CT in healthy females? b) Are osteoporotic patients lacking circulating monomeric CT? c) How is salmon CT (sCT) absorbed and cleared during treatment of diseases? d) Is there any effect of acute physical activity on circulating CT, PTH, PTHrP and bone metabolic markers? e) Is there an absorbance of PTHrP in milk by the neonate? and f) Are there any interactions between CT and PTHrP? In addition, by use of time-resolved dissociation and enhancement lanthanide fluorometry, the effo...
This paper studies the effects of the administration of calcitonin (CT) and Ca on post menopausal os...
of calcitonin (CT) and a possible interrelationship be-tween CT and parathyroid hormone, eight patie...
Female patients (n = 20) with osteoporosis, aged 66±5 yr were studied during a 24-h infusion of para...
The physiological role of calcitonin in mammals has been in question since it discovery. Many have s...
The association of hyperparathyroidism with Paget’s disease, the changes in bone mineral density aft...
This review reflects on the past, present, and future of translational research on calcitropic hormo...
This article summarizes our main findings concerning calcitonin (CT) physiology and pathology. We ha...
We have previously shown that co-administration of the transient osteoclast inhibitor, salmon calcit...
Maintaining normal calcium levels within the body (8.5-10 mg dL -1) requires the action of two hormo...
Calcitonin deficiency has been implicated in the pathogenesis of accelerated bone loss, especially i...
In this paper we present the results of a 12-month double-blind clinical multicenter study assessing...
Calcitonin, a potent hypocalcemic hormone produced by the C-cells of the thyroid, was first discover...
The therapeutic goal of increasing bone mass by co-treatment of parathyroid hormone (PTH) and an ost...
Recent studies have indicated that parathyroid hormone-related protein (PTHrP) may have important ac...
The purpose of this prospective open randomized controlled study was to examine the effect of cyclic...
This paper studies the effects of the administration of calcitonin (CT) and Ca on post menopausal os...
of calcitonin (CT) and a possible interrelationship be-tween CT and parathyroid hormone, eight patie...
Female patients (n = 20) with osteoporosis, aged 66±5 yr were studied during a 24-h infusion of para...
The physiological role of calcitonin in mammals has been in question since it discovery. Many have s...
The association of hyperparathyroidism with Paget’s disease, the changes in bone mineral density aft...
This review reflects on the past, present, and future of translational research on calcitropic hormo...
This article summarizes our main findings concerning calcitonin (CT) physiology and pathology. We ha...
We have previously shown that co-administration of the transient osteoclast inhibitor, salmon calcit...
Maintaining normal calcium levels within the body (8.5-10 mg dL -1) requires the action of two hormo...
Calcitonin deficiency has been implicated in the pathogenesis of accelerated bone loss, especially i...
In this paper we present the results of a 12-month double-blind clinical multicenter study assessing...
Calcitonin, a potent hypocalcemic hormone produced by the C-cells of the thyroid, was first discover...
The therapeutic goal of increasing bone mass by co-treatment of parathyroid hormone (PTH) and an ost...
Recent studies have indicated that parathyroid hormone-related protein (PTHrP) may have important ac...
The purpose of this prospective open randomized controlled study was to examine the effect of cyclic...
This paper studies the effects of the administration of calcitonin (CT) and Ca on post menopausal os...
of calcitonin (CT) and a possible interrelationship be-tween CT and parathyroid hormone, eight patie...
Female patients (n = 20) with osteoporosis, aged 66±5 yr were studied during a 24-h infusion of para...